Advertisement

Urticaria

  • Roberta Fachini Jardim Criado
  • Paulo Ricardo Criado
Chapter

Abstract

Acute urticaria and angioedema can be part of the clinical spectrum of anaphylaxis and thus present a lethal risk if left untreated. Chronic urticaria, on the other hand, is a disease with major negative impact on the patients’ daily activities and can therefore worsen their quality of life. Many causes are attributed in acute or chronic urticaria; however, most of them are spontaneous. The first line of treatment of urticaria are antihistaminic drugs, while for chronic urticaria The International Consensus of Urticaria recommend antihistamine doses of up to four-fold the standard doses. The second line of treatment consists of cyclosporine, omalizumab, or montelukast.

Keywords

Acute urticaria Chronic urticaria Urticaria physiopathology Urticaria treatment Antihistamine Omalizumab Cyclosporine D-dimer Mast cells 

References

  1. 1.
    Cousin F, Philips K, Favier B, Bienvenu J, Nicolas JF. Drug-induced urticaria. Eur J Dermatol. 2001;11:181–7.PubMedGoogle Scholar
  2. 2.
    Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW, et al. The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy. 2014;69:868–87.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Bernstein JA, Lang DM, Khan DA, Craig T, Dreyfus D, Hsieh F, Sheikh J, Weldon D, Zuraw B, Bernstein DI, Blessing-Moore J, Cox L, Nicklas RA, Oppenheimer J, Portnoy JM, Randolph CR, Schuller DE, Spector SL, Tilles SA, Wallace D. The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol. 2014;133:1270–7.CrossRefPubMedGoogle Scholar
  4. 4.
    Pite H, Wedi B, Borrego LM, Kapp A, Raap U. Management of childhood urticaria: current knowledge and practical recommendations. Acta Derm Venereol. 2013;93(5):500–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Sabroe RA. Acute urticaria. Immunol Allergy Clin North Am. 2014;34(1):11–21.CrossRefPubMedGoogle Scholar
  6. 6.
    Criado PR, Criado RF, Maruta CW, Reis VM. Chronic urticaria in adults: state-of-the-art in the new millenium. An Bras Dermatol. 2015;90(1):74–89.PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Criado PR, Jardim Criado RF, Sotto MN, Pagliari C, Takakura CH, Vasconcellos C. Dermal dendrocytes FXIIIA+ phagocytizing extruded mast cell granules in drug-induced acute urticaria. J Eur Acad Dermatol Venereol. 2013;27(1):e105–12.CrossRefPubMedGoogle Scholar
  8. 8.
    Hizal M, Tuzun B, Wolf R, Tuzun Y. The relationship between Helicobacter pylori IgG antibody and autologous serum test in chronic urticaria. Int J Dermatol. 2000;39:443–5.CrossRefPubMedGoogle Scholar
  9. 9.
    Federman DG, Kirsner RS, Moriarty JP, Concato J. The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticaria. J Am Acad Dermatol. 2003;49:861–4.CrossRefPubMedGoogle Scholar
  10. 10.
    Burova KP, Mallet AI, Greaves MW. Is Helicobacter pylori a cause of urticaria? Br J Dermatol. 1999;51:42.Google Scholar
  11. 11.
    Greaves MW. Chronic idiopathic urticaria and H pylori: not directly causative but could there be a link? ACI Int. 2001;13:23–6.Google Scholar
  12. 12.
    Tharp MD, Thirlby R, Sullivan TJ. Gastrin induces histamine release from human cutaneous mast cells. J Allergy Clin Immunol. 1984;74:159–65.CrossRefPubMedGoogle Scholar
  13. 13.
    Lessof MH, Gant V, Hinuma K, Murphy GM, Dowling RH. Recurrent urticaria and reduced diamine oxidase activity. Clin Exp Allergy. 1990;20:373–6.CrossRefPubMedGoogle Scholar
  14. 14.
    Maintz L, Novak N. Histamine and histamine intolerance. Am J Clin Nutr. 2007;85:1185–96.CrossRefPubMedGoogle Scholar
  15. 15.
    Asero R. Multiple intolerance to food additives. J Allergy Clin Immunol. 2002;110:531–2.CrossRefPubMedGoogle Scholar
  16. 16.
    Simon RA. Additive-induced urticaria: experience with monosodium glutamate(MSG). J Nutr. 2000;130:1063S–6S.CrossRefPubMedGoogle Scholar
  17. 17.
    Di Lorenzo G, Pacor ML, Mansueto P, Martinelli N, Esposito-Pellitteri M, Lo Bianco C, et al. Food-additive-induced urticaria: a survey of 838 patients with recurrent chronic idiopathic urticaria. Int Arch Allergy Immunol. 2005;138:235–42.CrossRefPubMedGoogle Scholar
  18. 18.
    Goga D, Vaillant L, Pandraud L, Mateu J, Ballon G, Beutter P. The elimination of dental and sinusal infectious foci in dermatologic pathology. A double-blind study in 27 cases confined to chronic urticaria. Rev Stomatol Chir Maxillofac. 1988;89:273–5.PubMedGoogle Scholar
  19. 19.
    Vaida GA, Goldman MA, Bloch KJ. Testing for hepatitis B virus in patients with chronic urticaria and angioedema. J Allergy Clin Immunol. 1983;72:193–8.CrossRefPubMedGoogle Scholar
  20. 20.
    Siddique N, Pereira BN, Hasan AS. Hepatitis C and urticaria: cause and effect? Allergy. 2004;59:668.CrossRefPubMedGoogle Scholar
  21. 21.
    Nenoff P, Domula E, Willing U, Herrmann J. Giardia lamblia – cause of urticaria and pruritus or accidental association? Hautarzt. 2006;57:518–20. 521–2CrossRefPubMedGoogle Scholar
  22. 22.
    Demirci M, Yildirim M, Aridogan BC, Baysal V, Korkmaz M. Tissue parasites inpatients with chronic urticaria. J Dermatol. 2003;30:777–81.CrossRefPubMedGoogle Scholar
  23. 23.
    Ismail MA, Khalafallah O. Toxocara canis and chronic urticaria in Egyptian patients. J Egypt Soc Parasitol. 2005;35:833–40.PubMedGoogle Scholar
  24. 24.
    Gulalp B, Koseoglu Z, Toprak N, Satar S, Sebe A, Gokel Y, et al. Ruptured hydatid cyst following minimal trauma and few signs on presentation. Neth J Med. 2007;65:117–8.PubMedGoogle Scholar
  25. 25.
    Pattison DA, Speare R. Strongyloidiasis in personnel of the Regional Assistance Mission to Solomon Islands (RAMSI). Med J Aust. 2008;189:203–6.PubMedGoogle Scholar
  26. 26.
    Marseglia GL, Marseglia A, Licari A, Castellazzi AM, Ciprandi G. Chronic urticaria caused by Hymenoleptis nana in an adopted girl. Allergy. 2007;62:821–2.CrossRefPubMedGoogle Scholar
  27. 27.
    Zuel-Fakkar NM, Abdel Hameed DM, Hassanin OM. Study of Blastocystis hominis isolates in urticaria: a case-control study. Clin Exp Dermatol. 2011;36:908–10.CrossRefPubMedGoogle Scholar
  28. 28.
    Kaji K, Yoshiji H, Yoshikawa M, Yamazaki M, Ikenaka Y, Noguchi R, et al. Eosinophilic cholecystitis along with pericarditis caused by Ascaris lumbricoides: a case report. World J Gastroenterol. 2007;13:3760–2.PubMedCentralPubMedCrossRefGoogle Scholar
  29. 29.
    Criado PR, Belda Junior W, Criado RF, Vasconcelos e Silva R, Vasconcellos C. Bedbugs (Cimicidae infestation): the worldwide renaissance of an old partner of human kind. Braz J Infect Dis. 2011;15:74–80.PubMedGoogle Scholar
  30. 30.
    Spiewak R, Lundberg M, Johansson G, Buczek A. Allergy to pigeon tick (Argas reflexus) in Upper Silesia, Poland. Ann Agric Environ Med. 2006;13:107–12.PubMedGoogle Scholar
  31. 31.
    Armentia A, Martin-Gil FJ, Pascual C, Martin-Esteban M, Callejo A, Martinez C. Anisakis simplex allergy after eating chicken meat. J Investig Allergol Clin Immunol. 2006;16:258–63.PubMedGoogle Scholar
  32. 32.
    Daschner A, De Frutos C, Valls A, Vega F. Anisakis simplex sensitization-associated urticaria: short-lived immediate type or prolonged acute urticaria. Arch Dermatol Res. 2010;302:625–9.CrossRefPubMedGoogle Scholar
  33. 33.
    Leznoff A, Josse RG, Denburg J, Dolovich J. Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol. 1983;119:636–40.CrossRefPubMedGoogle Scholar
  34. 34.
    Leznoff A, Sussman GL. Syndrome of idiopathic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol. 1989;84:66–71.CrossRefPubMedGoogle Scholar
  35. 35.
    Zauli D, Grassi A, Ballardini G, Contestabile S, Zucchini S, Bianchi FB. Thyroid autoimmunity in chronic idiopathic urticaria. Am J Clin Dermatol. 2002;3:525–8.CrossRefPubMedGoogle Scholar
  36. 36.
    Turktas I, Gokcora N, Demirsoy S, Cakir N, Onal E. The association of chronic urticaria and angioedema with autoimmune thyroiditis. Int J Dermatol. 1997;36:187–90.CrossRefPubMedGoogle Scholar
  37. 37.
    Rottem M. Chronic urticaria and autoimmune thyroid disease: is there a link? Autoimmun Rev. 2003;2:69–72.CrossRefPubMedGoogle Scholar
  38. 38.
    Konstantinou GN, Asero R, Maurer M, Sabroe RA, Schmid-Grendelmeier P, Grattan CE. EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria. Allergy. 2009;64:1256–68.PubMedCrossRefGoogle Scholar
  39. 39.
    Tedeschi A, Cottini M, Asero R. Simultaneous occurrence of chronic autoimmune urticaria and nonallergic asthma: a common mechanism? Eur Ann Allergy Clin Immunol. 2009;41:56–9.PubMedGoogle Scholar
  40. 40.
    Confino-Cohen R, Chodick G, Shalev V, Leshno M, Kimhi O, Goldberg A. Chronic urticaria and autoimmunity: associations found in a large population study. J Allergy Clin Immunol. 2012;129:1307–13.CrossRefPubMedGoogle Scholar
  41. 41.
    Cugno M, Marzano AV, Asero R, Tedeschi A. Activation of blood coagulation in chronic urticaria: pathophysiologic and clinical implications. Intern Emerg Med. 2010;5:97–101.CrossRefPubMedGoogle Scholar
  42. 42.
    Asero R, Tedeschi A, Riboldi P, Griffini S, Bonanni E, Cugno M. Severe chronic urticaria is associated with elevated plasma levels of D-dimer. Allergy. 2008;63:176–80.PubMedGoogle Scholar
  43. 43.
    Takahagi S, Mihara S, Iwamoto K, Morioke S, Okabe T, Kameyoshi Y, et al. Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria. Allergy. 2010;65:649–56.CrossRefPubMedGoogle Scholar
  44. 44.
    Konstantinou GN, Asero R, Ferrer M, Knol EF, Maurer M, Raap U, et al. EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria. Allergy. 2013;68:27–36.CrossRefPubMedGoogle Scholar
  45. 45.
    Augey F, Gunera-Saad N, Bensaid B, Nosbaum A, Berard F, Nicolas JF. Chronic spontaneous urticaria is not an allergic disease. Eur J Dermatol. 2011;21:349–53.PubMedGoogle Scholar
  46. 46.
    Caliskaner Z, Ozturk S, Turan M, Karaayvaz M. Skin test positivity to aeroallergens in the patients with chronic urticaria without respiratory disease. J Investig Allergol Clin Immunol. 2004;14:50–4.PubMedGoogle Scholar
  47. 47.
    Kozel MM, Mekkes JR, Bossuyt PM, Bos JD. Natural course of physical and chronic urticaria and angioedema in 220 patients. J Am Acad Dermatol. 2001;45:387–91.CrossRefPubMedGoogle Scholar
  48. 48.
    Młynek A, Zalewska-Janowska A, Martus P, Staubach P, Zuberbier T, Maurer M. How to assess disease activity in patients with chronic urticaria? Allergy. 2008;63:777–80.CrossRefPubMedGoogle Scholar
  49. 49.
    Grattan CEH. The urticaria spectrum: recognition of clinical patterns can help management. Clin Exp Dermatol. 2004;29:217–21.CrossRefPubMedGoogle Scholar
  50. 50.
    Malmros H. Auto serum test. Nord Med. 1946;29:150–1.Google Scholar
  51. 51.
    Sabroe RA, Greaves MW. Chronic idiopathic urticaria with functional autoantibodies: 12 years on. Br J Dermatol. 2006;154:813–9.CrossRefPubMedGoogle Scholar
  52. 52.
    Yıldız H, Karabudak O, Doğan B, Harmanyeri Y. Evaluation of autologous plasma skin test in patients with chronic idiopathic urticaria. Br J Dermatol. 2011;165:1205–9.CrossRefPubMedGoogle Scholar
  53. 53.
    Asero R, Tedeschi A, Riboldi P, Cugno M. Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal and-flare reaction much more frequently than frequently than autologous serum. J Allergy Clin Immunol. 2006;117:1113–7.CrossRefPubMedGoogle Scholar
  54. 54.
    Metz M, Gimenez-Arnau A, Borzova E, Grattan CE, Magerl M, Maurer M. Frequency and clinical implications of skin autoreactivity to serum versus plasma in patients with chronic urticaria. J Allergy Clin Immunol. 2009;123:705–6.CrossRefPubMedGoogle Scholar
  55. 55.
    Criado PR, Criado RFJ, Maruta CW, Martins JEC, Rivitti EA. Urticaria. An Bras Dermatol. 2005;80:613–30.CrossRefGoogle Scholar
  56. 56.
    Criado PR, Criado RFJ, Maruta CW, Machado CDA. Histamine, histamine receptors and antihistamines: new concepts. An Bras Dermatol. 2010;85:195–210.CrossRefPubMedGoogle Scholar
  57. 57.
    Pires JS, de Ue APF, Furlani EJ, de Souza PK, Rotta O. Dapsone as an alternative to the treatment of chronic urticaria nonresponsive to antihistamines. An Bras Dermatol. 2008;83:413–8.CrossRefGoogle Scholar
  58. 58.
    Criado RF, Criado PR, Martins JE, Valente NY, Michalany NS, Vasconcellos C. Urticaria unresponsive to antihistaminic treatment: an open study of therapeutic options based on histopathologic features. J Dermatolog Treat. 2008;19:92–6.CrossRefPubMedGoogle Scholar
  59. 59.
    Jauregui I, Ferrer M, Montoro J, Davila I, Bartra J, del Cuvillo A, et al. Antihistamines in the treatment of chronic urticaria. J Investig Allergol Clin Immunol. 2007;17:41–52.PubMedGoogle Scholar
  60. 60.
    Kalivas J, Breneman D, Tharp M, Bruce S, Bigby M. Urticaria: clinical efficacy of cetirizine in comparison with hydroxyzine and placebo. J Allergy Clin Immunol. 1990;86:1014–8.CrossRefPubMedGoogle Scholar
  61. 61.
    Zuberbier T, Bindslev-Jensen C, Canonica W, Grattan CE, Greaves MW, Henz BM, et al. EAACI/GA2LEN/EDF. EAACI/GA2LEN/EDF guideline: management of urticaria. Allergy. 2006;61:321–31.CrossRefPubMedGoogle Scholar
  62. 62.
    Asero R. Chronic unremitting urticaria: is the use of antihistamines above the licensed dose effective? A preliminary study of cetirizine at licensed and above-licensed doses. Clin Exp Dermatol. 2007;32:34–8.CrossRefPubMedGoogle Scholar
  63. 63.
    Black AK, Greaves MW. Antihistamines in urticaria and angioedema. Clin Allergy Immunol. 2002;17:249–86.PubMedGoogle Scholar
  64. 64.
    Kozel MM, Sabroe RA. Chronic urticaria: aetiology, management and current and future treatment options. Drugs. 2004;64:2515–36.CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    Weller K, Ziege C, Staubach P, Brockow K, Siebenhaar F, Krause K, et al. H1-antihistamine up-dosing in chronic spontaneous urticaria: patients’ perspective of effectiveness and side effects – a retrospective survey study. PLoS One. 2011;6:e23931.PubMedCentralPubMedCrossRefGoogle Scholar
  66. 66.
    Sanchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A. Treatment of recalcitrant chronic urticaria with nonsedating antihistamines: is there evidence for updosing? J Investig Allergol Clin Immunol. 2013;23:141–4.PubMedGoogle Scholar
  67. 67.
    Fedorowicz Z, van Zuuren EJ, Hu N. Histamine H2-receptor antagonists for urticaria. Cochrane Database Syst Rev. 2012;3:CD008596.Google Scholar
  68. 68.
    Grattan CE, O’Donnell BF, Francis DM, Niimi N, Barlow RJ, Seed PT, et al. Randomized double-blind study of cyclosporine in chronic ‘idiopathic’ urticaria. Br J Dermatol. 2000;143:365–72.CrossRefPubMedGoogle Scholar
  69. 69.
    Hollander SM, Joo SS, Wedner HJ. Factors that predict the success of cyclosporine treatment for chronic urticaria. Ann Allergy Asthma Immunol. 2011;107:523–8.CrossRefPubMedGoogle Scholar
  70. 70.
    Di Leo E, Nettis E, Aloia AM, Moschetta M, Carbonara M, Dammacco F, et al. Cyclosporine-A efficacy in chronic idiopathic urticaria. Int J Immunopathol Pharmacol. 2011;24:195–200.CrossRefPubMedGoogle Scholar
  71. 71.
    Vena GA, Cassano N, Colombo D, Peruzzi E, Pigatto P, Neo-I-30 Study Group. Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. J Am Acad Dermatol. 2006;55:705–9.CrossRefPubMedGoogle Scholar
  72. 72.
    Neverman L, Weinberger M. Treatment of chronic urticaria in children with antihistamines and cyclosporine. J Allergy Clin Immunol Pract. 2014;2:434–8.CrossRefPubMedGoogle Scholar
  73. 73.
    Kessel A, Toubi E. Cyclosporine-A in severe chronic urticaria: the option for long term therapy. Allergy. 2010;65:1478–82.CrossRefPubMedGoogle Scholar
  74. 74.
    Sagi L, Solomon M, Baum S, Lyakhovitsky A, Trau H, Barzilai A. Evidence for methotrexate as a useful treatment for steroid-dependent chronic urticaria. Acta Derm Venereol. 2011;91:303–6.CrossRefPubMedGoogle Scholar
  75. 75.
    Perez A, Woods A, Grattan CE. Methotrexate: a useful steroid-sparing agent in recalcitrant chronic urticaria. Br J Dermatol. 2010;162:191–4.CrossRefPubMedGoogle Scholar
  76. 76.
    Asero R. Oral cyclophosphamide in a case of cyclosporine and steroid-resistant chronic urticaria showing autoreactivity on autologous serum skin testing. Clin Exp Dermatol. 2005;30:582–3.CrossRefPubMedGoogle Scholar
  77. 77.
    O’Donnell BF, Barr RM, Black AK, Francis DM, Kermani F, Niimi N, et al. Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol. 1998;138:101–6.CrossRefPubMedGoogle Scholar
  78. 78.
    Pereira C, Tavares B, Carrapatoso I, Loureiro G, Faria E, Machado D, et al. Lowdose intravenous gammaglobulin in the treatment of severe autoimmune urticaria. Eur Ann Allergy Clin Immunol. 2007;39:237–42.PubMedGoogle Scholar
  79. 79.
    Mitzel-Kaoukhov H, Staubach P, Muller-Brenne T. Effect of high-dose intravenous immunoglobulin treatment in therapy-resistant chronic spontaneous urticaria. Ann Allergy Asthma Immunol. 2010;104:253–8.CrossRefPubMedGoogle Scholar
  80. 80.
    Maurer M, Altrichter S, Bieber T, Biedermann T, Brautigam M, Seyfried S, et al. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. J Allergy Clin Immunol. 2011;128:202–209.e5.CrossRefPubMedGoogle Scholar
  81. 81.
    Khan DA. Alternative agents in refractory chronic urticaria: evidence and considerations on their selection and use. J Allergy Clin Immunol Pract. 2013;1:433–440.e1.CrossRefPubMedGoogle Scholar
  82. 82.
    Saini S, Rosen KE, Hsieh HJ, Wong DA, Conner E, Kaplan A, et al. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria. J Allergy Clin Immunol. 2011;128:567–73.e1.CrossRefPubMedGoogle Scholar
  83. 83.
    Maurer M, Rosen K, Hsieh HJ, Saini S, Grattan C, Gimenez-Arnau A, et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med. 2013;368:924–35.CrossRefPubMedGoogle Scholar
  84. 84.
    Asero R, Tedeschi A, Cugno M. Treatment of chronic urticaria. Immunol Allergy Clin N Am. 2014;34:105–16.CrossRefGoogle Scholar
  85. 85.
    Chakravarty SD, Yee AF, Paget SA. Rituximab successfully treats refractory chronic autoimmune urticaria caused by IgE receptor autoantibodies. J Allergy Clin Immunol. 2011;128:1354–5.CrossRefPubMedGoogle Scholar
  86. 86.
    Arkwright PD. Anti-CD20 or anti-IgE therapy for severe chronic autoimmune urticaria. J Allergy Clin Immunol. 2009;123:510–1.CrossRefPubMedGoogle Scholar
  87. 87.
    Mallipeddi R, Grattan CE. Lack of response of severe steroid-dependent chronic urticaria torituximab. Clin Exp Dermatol. 2007;32:333–4.CrossRefPubMedGoogle Scholar
  88. 88.
    Wilson LH, Eliason MJ, Leiferman KM, Hull CM, Powell DL. Treatment of refractory chronic urticaria with tumor necrosis factor-alfa inhibitors. J Am Acad Dermatol. 2011;64:1221–2.CrossRefPubMedGoogle Scholar
  89. 89.
    Piconi S, Trabattoni D, Iemoli E, Fusi ML, Villa ML, Milazzo F, et al. Immune profiles of patients with chronic idiopathic urticaria. Int Arch Allergy Immunol. 2002;128:59–66.CrossRefPubMedGoogle Scholar
  90. 90.
    Hermes B, Prochazka AK, Haas N, Jurgovsky K, Sticherling M, Henz BM. Upregulation of TNF-alpha and IL-3 expression in lesional and uninvolved skin indifferent types of urticaria. J Allergy ClinImmunol. 1999;103:307–14.CrossRefGoogle Scholar
  91. 91.
    Reeves GE, Boyle MJ, Bonfield J, Dobson P, Loewenthal M. Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation. Intern Med J. 2004;34:182–6.CrossRefPubMedGoogle Scholar
  92. 92.
    Pho LN, Eliason MJ, Regruto M, Hull CM, Powell DL. Treatment of chronic urticaria with colchicine. J Drugs Dermatol. 2011;10:1423–8.PubMedGoogle Scholar
  93. 93.
    Noda S, Asano Y, Sato S. Long-term complete resolution of severe chronic idiopathic urticaria after dapsone treatment. J Dermatol. 2012;39:496–7.CrossRefPubMedGoogle Scholar
  94. 94.
    Engin B, Ozdemir M. Prospective randomized nonblinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticaria. J Eur Acad Dermatol Venereol. 2008;22:481–6.CrossRefPubMedGoogle Scholar
  95. 95.
    Khan S, Lynch N. Efficacy of montelukast as added therapy in patients with chronic idiopathic urticaria. Inflamm Allergy Drug Targets. 2012;11:235–43.CrossRefPubMedGoogle Scholar
  96. 96.
    Criado PR, Antinori LC, Maruta CW, Reis VM. Evaluation of D-dimer serum levels among patients with chronic urticaria, psoriasis and urticarial vasculitis. An Bras Dermatol. 2013;88:355–60.PubMedCentralPubMedCrossRefGoogle Scholar
  97. 97.
    Asero R, Tedeschi A, Cugno M. Heparin and tranexamic acid therapy may be effective in treatment-resistant chronic urticaria with elevated d-dimer: a pilot study. Int Arch Allergy Immunol. 2010;152:384–9.CrossRefPubMedGoogle Scholar
  98. 98.
    Samarasinghe V, Marsland AM. Class action of oral coumarins in the treatment ofa patient with chronic spontaneous urticaria and delayed-pressure urticaria. Clin Exp Dermatol. 2012;37:741–3.CrossRefPubMedGoogle Scholar
  99. 99.
    Chua SL, Gibbs S. Chronic urticaria responding to subcutaneous heparin sodium. Br J Dermatol. 2005;153:216–7.CrossRefPubMedGoogle Scholar
  100. 100.
    Parslew R, Pryce D, Ashworth J, Friedmann PS. Warfarin treatment of chronic idiopathic urticaria and angio-oedema. Clin Exp Allergy. 2000;30:1161–5.CrossRefPubMedGoogle Scholar
  101. 101.
    Karaayvaz M, Calişkaner Z, Turan M, Akar A, Ozturk S, Ozanguc N. Levothyroxine versus ketotifen in the treatment of patients with chronic urticaria and thyroid autoimmunity. J Dermatol Treat. 2002;13:165–72.CrossRefGoogle Scholar
  102. 102.
    Temboury Molina C, Alins Sahun Y, Cerecedo CI. Recurrent urticaria and autoimmune thyroiditis: the influence of thyroxin treatment on the outcome of the urticaria. An Pediatr (Barc). 2012;77:66–7.CrossRefGoogle Scholar
  103. 103.
    Gupta MA, Gupta AK. Chronic idiopathic urticaria and post-traumatic stress disorder (PTSD): an under-recognized comorbidity. Clin Dermatol. 2012;30:351–4.CrossRefPubMedGoogle Scholar
  104. 104.
    Hunkin V, Chung MC. Chronic idiopathic urticaria, psychological comorbidity and posttraumatic stress: the impact of alexithymia and repression. Psychiatr Q. 2012;83:431–47.CrossRefPubMedGoogle Scholar
  105. 105.
    Staubach P, Dechene M, Metz M, Magerl M, Siebenhaar F, Weller K, et al. High prevalence of mental disorders and emotional distress in patients with chronic spontaneous urticaria. Acta Derm Venereol. 2011;91:557–61.CrossRefPubMedGoogle Scholar
  106. 106.
    O’Donnell BF. Urticaria: impact on quality of life and economic cost. Immunol Allergy Clin N Am. 2014;34:89–104.CrossRefGoogle Scholar
  107. 107.
    Rabelo-Filardi R, Daltro-Oliveira R, Campos RA. Parameters associated with chronic spontaneous urticaria duration and severity: a systematic review. Int Arch Allergy Immunol. 2013;161:197–204.CrossRefPubMedGoogle Scholar
  108. 108.
    Sanchez-Borges M, Asero R, Ansotegui IJ, Baiardini I, Bernstein JA, Canonica GW, et al. Diagnosis and treatment of urticaria and angioedema: a worldwide perspective. World Allergy Organ J. 2012;5:125–47.PubMedCentralPubMedCrossRefGoogle Scholar
  109. 109.
    Ye YM, Jin HJ, Hwang EK, Nam YH, Kim JH, Shin YS. Coexistence of chronic urticaria and metabolic syndrome: clinical implications. Acta Derm Venereol. 2013;93:156–60.CrossRefPubMedGoogle Scholar
  110. 110.
    De Benedictis FM, De Benedictis D, Canonica GW. New oral H1 antihistamines in children: facts and unmeet needs. Allergy. 2008;63:1395–404. doi: https://doi.org/10.1111/j.1398–9995.2008.01771.x.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2018

Authors and Affiliations

  • Roberta Fachini Jardim Criado
    • 1
  • Paulo Ricardo Criado
    • 2
  1. 1.Department of DermatologyScholl of Medicine – ABCSanto AndréBrazil
  2. 2.Department of Dermatology, School of Medicine, Sao Paulo UniversitySão PauloBrazil

Personalised recommendations